A phase I and pharmacokinetic study of indisulam in combination with carboplatin
2007 · British Journal of Cancer · 32 citations
https://doi.org/10.1038/sj.bjc.6603606
A
Anthe S. Zandvliet
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
48
Papers
1.3K
Citations
18
h-index
29
i10-index
Anthe S. Zandvliet is an academic researcher from Certara (United States). The author has contributed to research in topics: Pharmacogenetics and Drug Metabolism & Cancer Treatment and Pharmacology & Reproductive Biology and Fertility. The author has an h-index of 18, co-authored 41 publications.
Papers by this author
worksA dose-escalation study of indisulam in combination with capecitabine (Xeloda) in patients with solid tumours
2008 · British Journal of Cancer · 17 citations
https://doi.org/10.1038/sj.bjc.6604300
Two-stage model-based clinical trial design to optimize phase I development of novel anticancer agents
2009 · Investigational New Drugs · 13 citations
https://doi.org/10.1007/s10637-008-9216-2
A phase I study of ridaforolimus in adult Chinese patients with advanced solid tumors
2013 · Journal of Hematology & Oncology · 8 citations
https://doi.org/10.1186/1756-8722-6-48
Population Pharmacokinetic Modeling of TV-46000, a Risperidone Long-Acting Subcutaneous Antipsychotic for the Treatment of Patients with Schizophrenia
2025 · Neurology and Therapy · 5 citations
https://doi.org/10.1007/s40120-025-00723-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat